These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 2582313

  • 1. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G, Piantino P, Cerchier A, Pecchio F.
    Minerva Med; 1985 Apr 14; 76(16):765-70. PubMed ID: 2582313
    [Abstract] [Full Text] [Related]

  • 2. [Gastrointestinal cancer antigen and carcinoembryonic antigen in chronic pancreatopathies and pancreatic tumors].
    Piantino P, Cerchier A, Tappero GF, Pecchio F, Ghisetti V.
    Minerva Med; 1985 Jul 14; 76(28-29):1331-4. PubMed ID: 4022426
    [Abstract] [Full Text] [Related]

  • 3. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N.
    Adv Intern Med; 1974 Jul 14; 19():413-33. PubMed ID: 4592719
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M, Happ J, Hottenrott C, Maul FD, Baum RP, Hör G, Encke A.
    Nuklearmedizin; 1986 Feb 14; 25(1):9-14. PubMed ID: 3459133
    [Abstract] [Full Text] [Related]

  • 5. [Studies on serum CEA levels measured by enzyme immunoassay using monoclonal CEA-antibodies].
    Takada S, Hoshi H, Ito F, Imai K, Yachi A.
    Gan To Kagaku Ryoho; 1984 Jul 14; 11(7):1487-91. PubMed ID: 6378102
    [Abstract] [Full Text] [Related]

  • 6. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K, Yamamoto T, Yoshioka K, Iida M, Miyagawa H, Yoshikawa T, Sugino S, Kondo M.
    Gan To Kagaku Ryoho; 1986 Jan 14; 13(1):101-8. PubMed ID: 3455804
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A, Caciagli M, Zampieri F, Ciampalini G, Carpi A, Spisni R, Colizzi C.
    Cancer Detect Prev; 1995 Jan 14; 19(2):183-95. PubMed ID: 7750106
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
    Staab HJ, Hornung A, Anderer FA, Kieninger G.
    Dtsch Med Wochenschr; 1984 Jul 27; 109(30):1141-7. PubMed ID: 6204834
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
    Czakó L, Takács T, Babarczy E, Dux L, Lonovics J.
    Orv Hetil; 1997 Nov 23; 138(47):2981-5. PubMed ID: 9432648
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A, Schlag P, Geisen HP, Schmidt-Gayk H.
    Eur J Surg Oncol; 1987 Jun 23; 13(3):197-201. PubMed ID: 3474158
    [Abstract] [Full Text] [Related]

  • 13. [Value of the determination of carcinoembryonic antigen (CEA) in benign and tumoral digestive pathology, chronic hepathopathies and hepatomas: study of 190 cases].
    Escudero Navarro JM, Rodrigo Saez L, Morcillo Herrera L, Faedo Presa I, Cornago Sánchez A, Pérez Alvarez R, García Saavedra L.
    Rev Esp Enferm Apar Dig; 1980 Sep 23; 58(3):267-74. PubMed ID: 6256829
    [No Abstract] [Full Text] [Related]

  • 14. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
    Schmiegel WH, Eberl W, Kreiker C, Kalthoff H, Bützow GH, Jessen K, Klapdor R, Soehendra N, Wargenau M, Classen M.
    Hepatogastroenterology; 1985 Jun 23; 32(3):141-5. PubMed ID: 2410346
    [Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M, Kazaka S, Kushibiki K, Ashida Y, Saito H, Yamamoto H, Furukawa T.
    Gan No Rinsho; 1984 Apr 23; 30(4):357-62. PubMed ID: 6587133
    [Abstract] [Full Text] [Related]

  • 16. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction.
    Del Favero G, Fabris C, Panucci A, Basso D, Plebani M, Baccaglini U, Leandro G, Burlina A, Naccarato R.
    Bull Cancer; 1986 Apr 23; 73(3):251-5. PubMed ID: 3530354
    [Abstract] [Full Text] [Related]

  • 17. [Recent progress in tumor markers of the digestive system].
    Mori T.
    Gan No Rinsho; 1983 May 23; 29(6):663-71. PubMed ID: 6876437
    [Abstract] [Full Text] [Related]

  • 18. [Tumor-associated markers in malignant lung neoplasms].
    Piancino G, Racca P, Rayneri W, Piantino P, Cerchier A, Pecchio F.
    Minerva Med; 1986 Jan 14; 77(1-2):19-25. PubMed ID: 3945411
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
    Meenakshi A, Kumar NS, Vijayshanker SG.
    Hum Antibodies; 2000 Jan 14; 9(4):223-9. PubMed ID: 11341176
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R, Kiefe C, Rose E, Sutton F, Brown J, Alpert E.
    Cancer Res; 1993 Jun 15; 53(12):2803-9. PubMed ID: 7684947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.